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Summary
Degron binding regulates the activities of the AAA+ Lon protease in addition to targeting proteins
for degradation. The sul20 degron from the cell-division inhibitor SulA is shown here to bind to
the N domain of E. coli Lon, and the recognition site is identified by crosslinking and scanning for
mutations that prevent sul20-peptide binding. These N-domain mutations limit the rates of
proteolysis of model sul20-tagged substrates and ATP hydrolysis by an allosteric mechanism. Lon
inactivation of SulA in vivo requires binding to the N domain and robust ATP hydrolysis but does
not require degradation or translocation into the proteolytic chamber. Lon-mediated relief of
proteotoxic stress and protein aggregation in vivo can also occur without degradation but is not
dependent on robust ATP hydrolysis. In combination, these results demonstrate that Lon can
function as a protease or a chaperone and reveal that some of its ATP-dependent biological
activities do not require translocation.
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Introduction
An Escherichia coli cell contains more than 4000 different proteins, with wide variations in
copy numbers. Under conditions that result in protein misfolding, about half of cytosolic
protein degradation in E. coli is dependent on the AAA+ Lon protease (Chung and
Goldberg, 1981). Lon appears to recognize some substrates by binding to degrons consisting
largely of hydrophobic residues that are exposed as a consequence of unfolding or
misfolding (Gur and Sauer, 2008). Lon also degrades natively folded proteins, including the
SulA cell-division inhibitor, which contains an exposed C-terminal degron that is recognized
by Lon (Higashitani et al., 1997; Gur et al., 2012). Lon proteases are present in most
bacteria, in archaea, and in the endosymbiotic organelles of eukaryotes (Gur, 2013). Lon is
necessary for rapid cell-cycle progression or pathogenicity in some bacteria, knockdown of
mitochondrial Lon kills lymphoma cells, and overexpression of Lon increases fungal
lifespan (Wright et al., 1996; Robertson et al., 2000; Ingmer and Brøndsted, 2009; Luce and
Osiewacz, 2009; Bernstein et al., 2012; Breidenstein et al., 2012; Gora et al., 2013).
Like other AAA+ proteases, Lon sequesters its proteolytic active sites within a chamber,
uses a hexameric ring and ATP hydrolysis to unfold and translocate proteins through a
narrow axial pore into this chamber, and recognizes substrates predominantly by binding to
degrons or peptide tags (Cha et al., 2010; Sauer and Baker, 2011). Unlike many AAA+
proteases, however, the AAA+ ATPase module and protease domain of Lon are part of a
single polypeptide, and degron binding regulates Lon ATPase and protease activity in
addition to serving a recognition function. For example, when otherwise identical proteins
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are tagged with either the sul20 or β20 degron, which correspond respectively to the C-
terminal 20 residues of SulA and a β-galactosidase sequence buried in the native protein, the
maximal rate of E. coli Lon degradation can differ by 5 fold or more (Higashitani et al.,
1997; Ishii and Amano, 2001; Gur and Sauer, 2008; 2009). These results suggest that degron
binding shifts Lon into conformations with higher or lower protease activity.
In addition to its AAA+ module and peptidase domain, E. coli Lon contains a family-
specific N domain that is necessary but not sufficient for hexamerization and has been
proposed to be involved in substrate binding (Ebel et al., 1999; Roudiak and Shrader, 1998;
2000; Melnikov et al., 2008; Adam et al., 2012). Consistently, N-domain mutations or
truncations result in defects in Lon activity in vitro (Cheng et al., 2012), but substrate
binding to the N domain has not been directly demonstrated. Crystal structures (in non-
native oligomeric states) are known for regions of the N domain, and recent electron-
microscopy studies suggest that formation of Lon dodecamers is also mediated by the N
domain (Li et al., 2005; 2010; Duman and Löwe, 2010; Vieux et al., 2013).
Here, we show that the sul20 degron binds to the N domain of E. coli Lon and identify
mutations that define this binding site.. Degron binding to this site is not required for
proteolysis of sul20-tagged substrates in vitro but enhances degradation by allosterically
activating protease activity. Using additional Lon mutations that affect ATP hydrolysis,
translocation, and proteolysis, we also probe the requirements for SulA inactivation and
suppression of proteotoxic stress in vivo. SulA inactivation requires binding to the sul20-
binding site in the N domain and ATP hydrolysis but does not require translocation or
proteolysis. Lon-mediated relief of proteotoxic stress and protein aggregation can also occur
without protein degradation but does not require robust ATP hydrolysis or a functional
sul20-binding site in the N domain. In combination, our results show that E. coli Lon can
function as a protease or as a chaperone, reveal that some biological activities do not require
translocation through the axial pore, and support a model in which substrate binding to
multiple sites on the Lon enzyme can alter its conformation and biological activities.
Results
The Lon N domain binds the sul20 degron
We initially sought to test if the sul20 degron binds to a site in the N domain of E. coli Lon.
However, N-domain fragments do not form stable hexamers (Li et al., 2010), raising
potential problems if substrate binding requires hexamerization or if interactions with
hydrophobic surfaces normally buried in subunit-subunit interfaces create spurious non-
specific binding. To circumvent these problems, we fused the Lon N domain to E. coli
ClpXΔN, a AAA+ enzyme that forms stable ring hexamers. Chimera307 contained the entire
Lon N domain (residues 1-307; Fig. 1A) fused to ClpXΔN, whereas chimera211 contained the
first 211 residues of Lon, which included a globular region of the N domain but not an
extended helical region (see, Fig. 2B). In addition, chimera211 contained disulfide bonds
between the subunits of ClpXΔN, which have been shown to stabilize functional covalent
hexamers (Glynn et al., 2012). Both chimeras supported degradation of an ssrA-tagged
substrate in the presence of ClpP, the proteolytic partner of ClpX (Fig. 1B). As ClpXΔN
hexamerization is required for functional interaction with ClpP (Stinson et al., 2013), these
results confirm that both fusion proteins can assemble into active hexamers.
As assayed by changes in fluorescence anisotropy, chimera307, chimera211, and LonS679A, a
variant with the active-site proteolytic serine mutated to alanine (Amerik et al., 1991),
bound to a fluorescently labeled sul20 peptide with KD's of ~2-5 μM, whereas ClpXΔN alone
did not bind this peptide (Fig. 1C). The binding of chimera211 and LonS679A to the
fluorescent peptide was inhibited by an unlabeled sul20 peptide but not by a control peptide
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(Fig. 1D). Thus, the sul20 peptide binds specifically to a site contained within the first 211
residues of the N domain of E. coli Lon.
Mapping the sul20 binding site
We attached a UV-activatable crosslinker that contained a biotin and cleavable disulfide to a
sul20 “bait” peptide. Following incubation of the bait peptide with Lon, we activated
crosslinking by UV irradiation, reduced the disulfide to remove the sul20 portion of the
crosslinked moiety, cleaved with trypsin, and enriched for biotinylated peptides. Mass
spectrometry identified a peptide with a mass (2022.8 Da) very close to that expected for
Lon residues 100-113 plus the biotin label (2022.9 Da), suggesting that the sul20 binding
site was within 14 Å (the linker length between the crosslinker and “bait”) of this peptide.
Next, we performed alanine-scanning mutagenesis of solvent-exposed residues within 14 Å
of residues 100-113 in the crystal structure of an N-domain fragment (3LJC.pdb; Li et al.,
2010). We mutated blocks of two or three residues, purified the variants, and assayed for
defects in sul20-peptide binding by fluorescence anisotropy. Mutating residues 14-15,
33-35, or 36-38 to alanines resulted in substantial loss of binding (Fig. 2A). All of these
residues were close in the 3LJC crystal structure, suggesting that all of these mutations
affect the same binding site (Fig. 2B). We focused further studies on the R33A/E34A/K35A
variant, henceforth called Lon33-35, which had one of the largest defects in sul20 binding.
Like the wild-type enzyme (Vieux et al., 2013), Lon33-35 sedimented as a mixture of
hexamers and dodecamers in analytical-centrifugation experiments (Fig. 2C).
An allosteric role for the sul20-binding site in the N domain
The sul20-binding surface in the N domain could be essential for efficient high-affinity
tethering of sul20-tagged substrates to Lon prior to transfer to the translocation and
degradation machinery or might function to enhance proteolytic activity of these substrates
by an allosteric mechanism (Gur and Sauer, 2009). To distinguish between these
possibilities, we assayed Lon33-35 degradation of a set of model substrates that are degraded
by wild-type Lon. These substrates included sul20- and β20-tagged derivatives of
cp6-SFGFP, a readily degraded circularly permuted variant of superfolder GFP, FITC-
casein, a fluorescent β20 peptide, and sul20-tagged native and unfolded variants of the
titinI27 domain (Gur and Sauer, 2008; 2009; Wohlever et al., 2013).
We initially assayed rates of Lon33-35 and wild-type Lon degradation of different
concentrations of cp6-SFGFP-sul20 by monitoring changes in native fluorescence. Lon33-35
degraded this substrate with a Vmax ~20-fold lower than wild-type Lon but with a similar
KM (Fig. 3A; Table 1). This result supports an allosteric model in which sul20-degron
binding to the 33-35 site in the wild-type N domain enhances proteolysis. It does not support
a model in which the function of degron binding to the 33-35 sites is to increase the local
concentration of a substrate that is then degraded directly by Lon, as this tethering model
predicts an increase in the KM for Lon33-35 degradation of cp6-SFGFP-sul20 but no change
in Vmax. We found that Lon33-35 degraded β20-cp6-SFGFP and FITC-casein with KM and
Vmax values similar to wild-type Lon (Fig. 3B, 3C; Table 1), establishing that the 33-35
substitutions do not cause general defects in Lon degradation of all substrates. In
combination, these results and experiments reported below support the existence of two
types of binding sites for the sul20 degron; the N-domain sites defined by the 33-35
substitutions, which appear to mediate allosteric activation of protease activity upon sul20
binding, and a distinct site or sites responsible for determining the KM for cp6-SFGFP-sul20
degradation.
At low concentrations, some Lon substrates can activate degradation of other substrates with
different degrons (Gur and Sauer, 2009). To test for an effect of the 33-35 mutations in this
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transactivation assay, we monitored cleavage of a fluorescent β20 peptide by Lon33-35 or
wild-type Lon as a function of increasing concentrations of a non-fluorescent sul20-tagged
protein, titinI27-sul20. As shown in Fig. 3D, low concentrations of titinI27-sul20 activated
β20 cleavage by wild-type Lon, as expected for allosteric activation, whereas higher
concentrations resulted in decreased cleavage, as expected for substrate competition for
general proteolytic machinery. By contrast, titinI27-sul20 activated Lon33-35 β20 cleavage to
a much smaller extent, supporting a role for sul20 binding to the 33-35 sites in the N domain
in allosteric activation of protease activity.
Lon33-35 hydrolyzed ATP at a rate ~2.5 slower than wild-type Lon in the presence of
saturating cp6-SFGFP-sul20 (Fig. 3E; Table 1). Modest decreases in the rate of ATP
hydrolysis result in very slow degradation of GFP substrates by ClpXP (Martin et al., 2008a;
Nager et al., 2011), and reduced ATPase stimulation probably amplifies the Vmax defect for
Lon33-35 degradation of cp6-SFGFP-sul20. Indeed, compared to wild type, Lon33-35 showed
smaller but still substantial Vmax defects in degrading native titinI27-sul20 and denatured
CM-titinI27-sul20 (Table 1), with the latter variant being unfolded by carboxymethylation of
cysteines normally buried in the protein core. For these substrates, KM for Lon33-35
degradation was also increased compared to wild-type Lon (Table 1). Thus, the 33-35
mutations alter the kinetics of degradation of sul20-tagged substrates in ways that depend on
properties of the tagged protein. Indeed, the KM for sul20-tagged substrates by wild-type
Lon can also vary substantially depending on the model substrate (Wohlever et al., 2013).
No simple model allowed quantitative fitting of all of these experimental results, an
unsurprising outcome given the complexity of this system.
Requirements for SulA inactivation in vivo
Inactivation of SulA by Lon is required for resumption of growth following repair of UV-
induced DNA damage (Gottesman et al., 1981). To test the importance of different Lon
activities in SulA inactivation, we used mutations that prevent or diminish specific
biochemical functions. One mutation (S679A) prevents proteolysis by inactivating the
peptidase active sites. We also used Lon variants expected to be defective in substrate
translocation as a consequence of the Y398A mutation in the axial pore, variants expected to
be defective in ATP hydrolysis as a consequence of the E424Q mutation in the Walker-B
motif, and variants containing the 33-35 mutations. For these studies, wild-type Lon or
mutant variants were cloned into low-copy plasmids, which were transformed into E. coli
strains lacking the chromosomal lon gene. Following UV irradiation, plasmids expressing
wild-type Lon, LonS679A, or LonY389A/S679A rescued growth (Fig. 4A). Western blots
revealed that these Lon variants were expressed at levels similar to or slightly lower than
chromosomal Lon (Fig. 4B). Overexpression of LonS679A was previously shown to
inactivate SulA in vivo (Van Melderen and Gottesman, 1999). Our results confirm that Lon
degradation is not required for SulA inactivation, even when the enzyme is expressed at
cellular levels roughly comparable to normal cellular Lon levels. Our results also suggest
that efficient translocation into the proteolytic chamber is unnecessary for inactivation, as
LonY389A/S679A should be translocation defective. By contrast, the empty vector and
plasmids expressing Lon33-35, LonE424Q, and LonE424Q/S679A failed to rescue growth (Fig.
4A), even though these variants were also expressed at levels similar to the other variants
(Fig. 4B). Thus, Lon inhibition of SulA appears to require binding to the N-domain site
defined by the 33-35 mutations as well as an activity affected by the E424Q mutation but
not by the Y398A mutation.
To confirm that LonY398A and LonE424Q were not defective in binding the sul20 degron and
had the expected biochemical phenotypes, we purified both proteins and characterized their
activities in vitro. Both mutants bound the sul20 peptide (Fig. 4C), with LonE424Q having
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slightly higher affinity. Thus, the inability of LonE424Q and LonE424Q/S679A to inactivate
SulA in vivo is not correlated with a binding defect. As expected, LonE424Q displayed
reduced rates of both basal and substrate-stimulated ATP hydrolysis (Fig. 4D). This reduced
activity probably accounts for its inability to inactivate SulA. By contrast, LonY398A had
basal ATP-hydrolysis activity similar to wild-type Lon, but displayed substantially reduced
rates of ATP hydrolysis in the presence of sul20- or β20-tagged substrates (Fig. 4D). Thus, a
high level of substrate stimulation of ATPase activity does not appear to be important for
SulA inactivation. LonY398A did not degrade the unfolded CM-titinI27-sul20 or CM-titinI27-
β20 substrates (Fig. 4E), a property consistent with the expected defect in translocation of
substrates. Indeed, mutations analogous to Y398A in the axial pores of other AAA+
proteases also prevent substrate translocation and degradation (Siddiqui et al., 2004;
Hinnerwisch et al., 2005; Park et al., 2005; Martin et al., 2008b). LonE424Q translocated and
degraded CM-titinI27-sul20 and CM-titinI27-β20 at a very slow rate (Fig. 4F), suggesting
that its very slow rate of ATP hydrolysis allows a correspondingly slow rate of proteolysis.
Suppression of proteotoxic stress occurs without degradation
We also tested the ability of different Lon variants to support growth of cells subjected to
proteotoxic stress by high temperature, the absence of the chromosomal ClpXP and Lon
proteases, and low levels of the DnaJ and DnaK chaperones (Tomoyasu et al., 2001). In this
background at 42 °C, expression of wild-type Lon from a low-copy plasmid allowed robust
growth, as did expression of Lon33-35, LonE424Q, Lon33-35/S679A, and LonE424Q/S679A (Fig.
5A). Thus, degradation, robust ATP hydrolysis, and binding of client proteins to the sul20
site in the N domain are not required for Lon's ability to suppress proteotoxic stress.
Expression of LonS679A provided partial rescue, whereas expression of LonY398A/S679A
gave no rescue (Fig. 5A). The latter result suggests that substrate translocation is required
for suppression of proteotoxic stress, although the inactivity of LonY398A/S679A could
potentially arise from another defect conferred by the Y398A mutation (see Discussion).
The plasmid-expressed Lon variants used in these assays were again expressed at levels
similar to each other and to Lon expressed from its normal chromosomal location (Fig. 5B).
We note that LonS679A was partially active, whereas Lon33-35/S679A and LonE424Q/S679A
were as active as wild-type Lon. These results suggest that the S679A mutation destabilizes
the Lon conformation that is active in relieving stress, whereas the 33-35 and E424Q
mutations stabilize this conformation. Indeed, LonE424Q bound the sul20 peptide ~5-fold
more tightly than LonS679A (Fig. 1C, 4C), which could also reflect differential stabilization
of different Lon conformations by these mutations. Notably, the Lon mutants that were
active in inhibition of SulA were largely inactive in suppressing proteotoxic stress and vice
versa (Fig. 4A, 5A), emphasizing that these activities occur by distinct mechanisms.
Under the conditions of the proteotoxic-stress assay, ~1.5% of intracellular proteins are
recovered as insoluble aggregates both in Δlon and in Δlon ΔclpXP cells, which led to the
proposal that Lon degrades misfolded proteins that accumulate when DnaK and DnaJ are
limiting (Tomoyasu et al., 2001; Rosen et al., 2002). To test this model, we purified
aggregated proteins from cells without Lon and cells expressing wild-type Lon,
Lon33-35/S679A, or LonE424Q/S679A. As monitored by SDS-PAGE and straining with
Coomassie Blue, the levels of aggregated protein were comparable in cells expressing wild-
type Lon and both proteolytically inactive double mutants and were substantially lower than
the levels in cells with no Lon (Fig. 5C). Thus, Lon can suppress aggregation by a
mechanism that does not require proteolysis, robust ATP hydrolysis, or the 33-35 N-domain
sul20 binding site.
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Discussion
The biochemical and genetic experiments described here provide evidence that the N
domain of E. coli Lon binds the sul20 degron and this binding regulates proteolysis
allosterically. A set of spatially adjacent residues in the N domain is required for efficient
degradation of sul20-tagged substrates. For example, the 33-35 substitutions in the N
domain dramatically weaken binding to a sul20 peptide, reduce Vmax for degradation of
sul20-tagged substrates, and prevent Lon relief of SulA inhibition of cell division following
DNA damage. Lon33-35 degrades some model substrates with steady-state kinetics similar to
wild-type Lon, demonstrating that the 33-35 site is only required for the binding and/or
efficient degradation of a subset of substrates. These mutations also prevent efficient
transactivation of cleavage of a β20 peptide by a sul20-tagged protein, and alter stimulation
of ATP hydrolysis by sul20-tagged substrates. These results support a model in which
binding of the sul20 degron to the 33-35 site causes allosteric changes in the conformation
of wild-type Lon that stimulate ATP hydrolysis and proteolysis. Although SulA is restricted
to γ proteobacteria, Lon residues 33-35 are highly conserved across proteobacteria and
Gram-positive bacteria, suggesting that this site serves to bind substrates with sul20-related
degrons in these organisms.
The sul20 degrons of some cp6-SFGFP-sul20 molecules are proteolytically clipped by Lon
without global degradation, implying that the sul20 tag is the first segment of the substrate
to pass through the axial pore and enter the degradation chamber (Wohlever et al., 2013).
However, we find that the sul20 degron also binds to a distinct site in the N domain of Lon.
Lon33-35 degrades cp6-SFGFP-sul20 with the same KM as wild-type Lon, a fact inconsistent
with a model in which the sul20 degron of this substrate initially binds to the N domain and
is subsequently transferred to the axial pore. Rather, it appears that the sul20 degrons of
some substrate molecules bind to the N domain and allosterically activate proteolysis of
other substrate molecules whose degrons are independently engaged by the pore. Indeed,
this model is supported by transactivation experiments reported here and previously (Gur
and Sauer 2009). We also find that the Y398A mutation, which truncates a highly conserved
aromatic side chain in the axial pore, prevents degradation of unfolded substrates bearing the
sul20 or β20 degrons, dramatically reduces the maximal level of stimulation of ATP
hydrolysis by these substrates, but does not impair binding of the sul20 degron to the N
domain. These results are consistent with independent binding of sul20 degrons on different
substrate molecules to the N domain and to the axial pore. Studies with other AAA+
proteases show that mutations corresponding to Y398A prevent or greatly slow the rate of
substrate translocation (Siddiqui et al., 2004; Hinnerwisch et al., 2005; Park et al., 2005;
Martin et al., 2008b). Thus, both allosteric activation via degron binding to the N domain
and interaction of a translocating segment of polypeptide with the axial-pore loops appear to
be required for normal coordination of substrate binding, ATP hydrolysis, and substrate
translocation by Lon.
E. coli SulA, which inhibits cell division by binding to FtsZ (for review, see Löwe et al.,
2004), can be inactivated by Lon in the absence of degradation. Van Melderen and
Gottesman (1999) showed that overproduction of proteolytically inactive LonS679A rescued
cell growth after UV irradiation, but LonS679A with a Walker-A mutation was not active in
this assay. Because the Walker-A motif is required for ATP binding and hydrolysis, they
proposed that LonS679A inactivates SulA by unfolding and translocating it into the inert
proteolytic chamber of the mutant enzyme. Our results using LonE424Q, a Walker-B mutant,
show that a robust level of ATP hydrolysis is required to inactivate SulA. However,
LonY398A, which appears to be defective in substrate translocation, is fully active in
inhibiting SulA in vivo. Together, these results suggest that an activity, which depends upon
robust ATP hydrolysis but not upon efficient substrate translocation, is required for
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degradation-independent inhibition of SulA by Lon. The sul20 degron of SulA is not
involved in FtsZ binding and should be accessible to Lon in the complex, based upon the
crystal structure of Pseudomonas aeruginosa FtsZ•SulA (Higashitani et al., 1997; Cordell et
al., 2003). It is possible, therefore, that Lon binds the sul20 degrons of one or more SulA
molecules bound to FtsZ, with ATP hydrolysis then driving conformational changes in the N
domains that allow Lon to strip SulA from FtsZ and prevent its rebinding. Indeed, regions of
the Lon N domain have been shown to undergo nucleotide-dependent motions (Cheng et al.,
2012).
Gur and Sauer (2009) found that the β20 degron, which is hydrophobic and likely to be
similar to degrons in most misfolded proteins, stabilizes a Lon conformation with high
ATPase activity and little or possibly no protease activity. In this conformation, they
proposed that Lon unfolds β20-tagged substrates by translocating them through the axial
pore but then releases them without degradation, giving misfolded proteins a chance to
refold correctly. Although this model has not been ruled out, our SulA-inactivation results
suggest that Lon can perform mechanical functions that require robust ATP hydrolysis but
are not coupled to substrate translocation or degradation. Thus, the β20-stabilized
conformation of Lon that hydrolyzes ATP rapidly may be one in which translocation-
independent conformational changes can be coupled to protein remodeling reactions.
The Lon enzymes from yeast, mammals, and certain bacteria appear to mediate chaperone
activity that is independent of proteolysis (Rep et al., 1996; Hori et al., 2002; Lee et al.,
2004; Coleman et al., 2009). Indeed, in E. coli, we find that the protease-defective
Lon33-35/S679A and LonE424Q/S679A mutants suppress proteotoxic stress and protein
aggregation as well as the wild-type Lon enzyme. Thus, proteolytically inactive Lon variants
can function as chaperones, and wild-type Lon may also prevent aggregation of misfolded
proteins by a degradation-independent mechanism. Many chaperones functions by binding
to exposed hydrophobic patches in client proteins (Fenton et al., 2004; Vabulas et al., 2010),
and such binding could also be important for Lon suppression of aggregation. Consistent
with this model, the E424Q mutation dramatically reduces ATP hydrolysis but does not alter
chaperone activity. If simple binding of misfolded proteins to Lon suppresses their
aggregation, then the inactivity of LonY398A/S679A in the stress assay is likely to arise from
perturbations in the binding of specific substrates in or near the axial pore, as homologous
mutations in the pores of ClpX and ClpA reduce binding of specific degrons (Siddiqui et al.,
2004; Hinnerwisch et al., 2005; Martin et al., 2008b). Alternatively, the low level of ATP
hydrolysis mediated by LonE424Q may be sufficient to remodel misfolded proteins, allowing
them to refold properly rather than aggregating. In this model, the inactivity of
LonY398A/S679A could also be explained by its translocation defect. Because Lon33-35/S679A
is fully active in the proteotoxic-stress assay, binding of the Lon N domain to sul20-like
degrons does not appear to be important in suppressing protein aggregation.
Our present results and previous studies (Gur and Sauer, 2009) provide evidence for three
distinct activities of E. coli Lon. These activities are likely to correspond to different
conformations of the hexamer and/or dodecamer, with the binding of certain degrons
stabilizing specific conformations. The proteolytic activity of Lon requires ATP-fueled
translocation into the degradation chamber. Both hexamers and dodecamers have proteolytic
activity, albeit with different substrate profiles (Vieux et al., 2013). Another activity, which
mediates degradation-independent inactivation of SulA by variants such as LonY398A/S679A,
appears to involve remodeling that requires robust ATP hydrolysis but is translocation
independent. A third activity suppresses aggregation of misfolded proteins by a degradation-
independent mechanism that does not require robust ATP hydrolysis and may or may not
involve translocation. The second and third activities are likely to correspond to different
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enzyme conformations, but whether hexamers or dodecamers have both activities remains to
be determined.
The family-specific N domains of the ClpX and ClpA AAA+ unfoldases serve as binding
platforms for some substrates and adaptor proteins but can be deleted without compromising
hexamer formation or robust degradation of certain substrates by ClpXP and ClpAP (Sauer
and Baker, 2011). By contrast, the N domain of Lon is more highly integrated into overall
enzyme architecture and function, including substrate binding, hexamer and dodecamer
formation, and allosteric control of ATP hydrolysis and protease activity. Understanding in
structural and dynamic terms how the N domain accomplishes these tasks is an important
future challenge.
Materials and Methods
Protein cloning, expression, and purification
Variants of E. coli Lon were cloned into pBAD33 or a variant in which the chloramphenicol
resistance marker of pBAD33 was replaced with an ampicillin resistance marker from
pSH21. E. coli ClpXΔN and chimeras were cloned into HTUA vector and contained an N-
terminal His6 tag followed by a TEV protease site. Chimera307 contained Lon residues
1-307, a two residue scar (EL, resulting from cloning into a Sac I restriction site), and
ClpXΔN (residues 62-424 of wild-type ClpX). Chimera211 contained Lon residues 1-211, a
GSSG linker, the EL dipeptide, and ClpXΔN. In addition, chimera211 contained the C39S
Lon mutation and C169S ClpX mutation to remove exposed cysteines and the ClpX T66C
and P388C mutations to form inter-subunit disulfide bonds to stabilize hexamer formation
(Glynn et al., 2012). ClpP was cloned into a pET22b vector with a His6 tag on the C-
terminus. TitinI27 variants were cloned into a pSH21 vector with an N-terminal His6 tag.
β20-cp6-SF GFP and cp6-SFGFP-sul20 were cloned into a pCOLADuet1 vector with an N-
terminal His6 tag followed by a PreScission protease site. Mutations were generated either
by QuickChange PCR (Stratagene) or by standard PCR techniques.
Lon was over-expressed with minor modifications from a method described previously
(Wohlever et al., 2013). Briefly, cells were grown at 37 °C until OD600 = 1.0, induced with
0.2% arabinose at 37 °C for 3.5 h, harvested, and resuspended in LBA buffer [100 mM
potassium phosphate (pH 6.5), 1 mM DTT, 1 mM EDTA, and 10% glycerol] to a final
volume of 20 mL. Cells were incubated with lysozyme before sonication, and the crude cell
lysate was cleared by high-speed centrifugation. The cleared lysate was incubated on ice for
20 min with 2 μL of benzonase (250 U/mL, Sigma) and then bound to P11 phosphocellulose
resin (Whatman) equilibrated in LBA buffer. This resin was washed twice with LBA buffer
and once with LBA buffer plus 100 mM potassium phosphate (pH 6.5). Lon was eluted from
the P11 resin using LBA buffer plus 300 mM potassium phosphate (pH 6.5). The eluant was
filtered to remove phosphocellulose, polyethyleneimine (PEI) was added to a final
concentration of 0.12% to precipitate nucleic acids, additional phosphocellulose was added
to remove excess PEI, and the mixture was filtered, concentrated, and chromatographed on
an S200 column (GE Healthcare) equilibrated in 50 mM HEPES (pH 7.5), 2 M NaCl, and 1
mM DTT. Peak fractions from this column were pooled, buffer exchanged into storage
buffer [50 mM HEPES (pH 7.5), 150 mM NaCl, 10 μM EDTA, 1 mM DTT, and 10%
glycerol] and frozen at –80 °C.
E. coli ClpP, cp6-SFGFP-sul20, β20-cp6-SFGFP, and titinI27 variants were expressed,
purified, and carboxymethylated (if necessary) as described (Kenniston et al., 2003; Gur and
Sauer, 2009; Glynn et al., 2012; Wohlever et al., 2013). For 35S-labeling, cells were grown
in a rich defined medium lacking methionine (TekNova) until OD600 = 0.6 , and 35S-
methionine (Perkin-Elmer) was added after 20 min of induction with 1 mM IPTG. 35S-
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labeled proteins were purified through the Ni-NTA step and then mixed at a 1:19 ratio with
purified unlabeled substrate.
Cells expressing ClpXΔN and Lon-ClpXΔN chimeras were grown until OD600 = 1.0, induced
with 1 mM IPTG for 3.5 h at room temperature, harvested, resuspended in lysis buffer [25
mM HEPES (pH 7.5), 400 mM NaCl, 100 mM KCl, 20 mM imidazole, 10% glycerol, and
10 mM 2-mercaptoethanol] to a total volume of 20 mL, and lysed by incubation with
lysozyme and sonication. Following lysis, 2 μL of benzonase (250 U/mL, Sigma) and PMSF
(final concentration 1 mM) were added, the lysate was cleared by high-speed centrifugation,
and the supernatant was bound to Ni-NTA resin equilibrated in lysis buffer. The resin was
washed with 30 mL of lysis buffer and eluted with lysis buffer plus 250 mM imidazole. For
ClpXΔN and chimera307, the eluant was chromatographed on S300 column (GE Healthcare)
equilibrated in 50 mM Tris (pH 8.0), 300 mM KCl, 1 mM DTT, and 10% glycerol.
Appropriate fractions were pooled, concentrated, and frozen at –80 °C. After elution of
chimera211 from the Ni-NTA resin, the protein was buffer exchanged into low-salt buffer
[25 mM HEPES (pH 7.5), 50 mM KCl, 5 mM MgCl2, 1 mM DTT, and 10% glycerol],
incubated with 1 μM TEV protease for 90 min at room temperature to remove the His6 tag,
chromatographed on an S300 column as described above, and treated with copper
phenanthroline to catalyze disulfide-bond formation between subunits as described (Glynn
et al., 2012). The disulfide-bonded chimera211 was purified on a Superose 6 column,
concentrated, and frozen at –80 °C as described above, except in a buffer lacking DTT.
Anti-Lon antibodies used for Western blots were a gift from the Baker lab (MIT).
Peptides
Peptides were synthesized, purified by reverse-phase HPLC, and masses were verified by
mass spectrometry. The F-β20-Q peptide (sequence Z-QLRSLNGEWRFAWFPAPEAV-
nY-A, where Z is a para-aminobenzoic acid fluorophore and nY is a nitrotyrosine quencher)
was dissolved in dimethylsulfoxide and concentration was determined by absorbance (ε381 =
2200 M−1 cm−1). The sul20 peptide (sequence ASSHATRQLSGLKIHSNLYH) was
dissolved in 50 mM HEPES (pH 7.5) and concentration was measured by absorbance (ε280
= 1490). The sul20 peptide with an N-terminal fluorescein was dissolved in 25 mM Tris (pH
8.0) and concentration was determined by absorbance (ε495 = 83,397 M-1 cm-1).
Biochemical assays
Unless noted, biochemical assays were performed in 25 mM Tris (pH 8.0), 100 mM KCl, 10
mM MgCl2, at 37 °C using enzyme concentrations calculated for hexamer equivalents.
Kinetic and anisotropy assays were performed in a SpectraMax M5 plate reader using 384-
well clear plates (Corning) for absorbance assays and 96-well flat bottom ½-area plates
(Corning) for fluorescence assays. ATPase assays contained supplemental 5 mM DTT, 2
mM ATP, lactate dehydrogenase (10 U/mL), and an ATP regeneration system [rabbit
muscle pyruvate kinase (Sigma, 10 U/mL), 20 mM phosphoenolpyruvate (Sigma)]. The rate
of ATP hydrolysis was measured by monitoring changes in absorbance at 340 nm, and
reactions were initiated by the addition of MgCl2 that had been pre-warmed to 37 °C.
Degradation assays contained supplemental 1 mM DTT, an ATP regeneration system, and 2
mM ATP, which was used to initiate the reaction. Fluorescent substrates were incubated in
plate reader until the fluorescence was constant prior to initiation of degradation. For
degradation assays monitored by SDS-PAGE, 10 μL aliquots were taken at specified time
points and mixed with 3.3 μL of 4X loading buffer [8% SDS, 250 mM Tris (pH 6.8), 40%
glycerol, 160 mM DTT, and bromophenol blue]. The rate of degradation of 35S-labeled
titinI27-sul20 variants was determined by measuring the amount of soluble radioactive
products following precipitation with ice-cold trichloroacetic acid (Gottesman et al., 1998).
The binding of fluorescent sul20 peptide to LonS679A and variants was measured in the
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presence of 1 mM ATPγS to prevent substrate translocation; fluorescence anisotropy values
were corrected for G-factor and scattering and fitted to a hyperbolic equation to determine a
KD value. Sedimentation-velocity ultracentrifugation was performed as described, except
using proteolytically active Lon33-35 (Vieux et al., 2013).
Cross-linking and mass spectrometry
Reactions were performed in the dark until the photo-activation step. The sul20 peptide (1
mM in 50 mM HEPES (pH 7.5), 150 mM NaCl, 10 μM EDTA, 10% glycerol) was
incubated with 1 mM Sulfo-SBED (Pierce) for 30 min at room temperature, precipitated
material was removed by centrifugation, and unreacted crosslinker was removed by dialysis
using a 2 kDa MWCO membrane. The crosslinker-modified sul20 peptide (200 μM) was
incubated with 10 μM LonS679A (hexamer equivalents), 1 mM ATPγS, and 1 mM MgCl2 at
room temperature for 5 min. Crosslinking was initiated by UV irradiation (365 nm) with a
handheld lamp at a distance of 2 cm for 15 min. To reduce the disulfide bond linking the
sul20 peptide to the crosslinker and Lon, 100 mM 2-mercaptoethanol was added and the
reaction was incubated at room temperature for 1 h. Free sul20 peptide was removed by two
consecutive microbio spin columns (BioRad). Labeling of Lon was verified by Western
blotting with an anti-biotin antibody. The modified Lon protein was digested with
sequencing grade trypsin (Roche) using a 1:100 enzyme:substrate ratio at 37 °C for 14 h,
and cleavage was quenched with 1 mM TLCK. Biotinylated peptides were enriched by
passage over a Monomeric Avidin Resin (Pierce) and were eluted from this column with
100 mM glycine buffer (pH 2.8). Samples were loaded onto a reverse phase protein trap,
which was desalted on-line and eluted isocratically, and then analyzed by nanospray LC-MS
using a QSTAR Elite quadrupole-time-of-flight mass spectrometer. Deconvolution of the
electrospray data to generate molecular-weight spectra was performed with the BioAnalyst
software included with the QSTAR Elite data system.
Biological assays
For assays of SulA inactivation in vivo, E. coli strain W3110 Δlon::kanR was transformed
with pBAD33 or plasmid variants (camR) expressing wild-type Lon or Lon mutants. Cells
were grown in Luria-Bertani (LB) broth to an OD600 of 0.9 – 1.3, diluted into fresh LB broth
to an OD600 of 0.25, and 10-fold serial dilutions were prepared. 10 μL of each dilution was
spotted onto an LB-agar plate containing 25 μg/mL kanamycin and 10 μg/mL
chloramphenicol. The plate was exposed to 254 nm UV light from a handheld lamp at a
distance of 5 cm for 10 s and was incubated overnight in the dark at 37 °C.
E. coli strain BB7357 expresses the DnaJ and DnaK chaperones from an IPTG-inducible
promoter and lacks the chromosomal lon, clpX, and clpP genes (Tomoyasu et al., 2001). At
42 °C, BB7357 grows poorly when IPTG levels are low but an otherwise isogenic lon+
strain grows well under these conditions. For proteotoxic-rescue assays, we transformed
strain BB7357 with a pBAD33 variant encoding ampicillin resistance (empty vector) or
derivatives expressing wild-type Lon or Lon mutants. Cells were grown at 30 °C in LB
broth plus 1 mM IPTG until late-log phase, diluted to a final OD600 of 0.1, and serial 5-fold
dilutions were prepared in LB broth. Small aliquots of each dilution were then spotted onto
LB agar plates containing 25 μM IPTG, 25 μg/mL kanamycin, 10 μg/mL chloramphenicol,
and 100 μg/mL ampicillin, and the plates were incubated overnight at 30 or 42 °C. For
assays of protein aggregation, cells were grown at 30 °C in LB broth plus 100 μM IPTG to
mid-log phase, the culture was split in two, grown for an additional 60 min at 30 or 42 °C,
and then harvested. Aggregated proteins were purified by the method described by
Tomoyasu et al. (2001), separated by SDS-PAGE, and visualized by staining with
Coomassie Blue.
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Figure 1.
The N domain of Lon binds the sul20 degron. (A) Domain organization of E. coli Lon and
Lon-ClpXΔN chimeras. (B) In combination with E. coli ClpP, chimera201 or chimera307
supported degradation of CM-titinI27-ssrA as assayed by SDS-PAGE. No substrate
degradation was observed using ClpP alone. Pyruvate kinase (pk) was present for ATP
regeneration. (C) Binding of a fluorescein-labeled sul20 peptide (200 nM) to LonS679A,
chimera211, chimera307, or ClpXΔN was assayed by changes in fluorescence anisotropy
(excitation 494 nm; emission 521 nm). Values are means ± SEM (N ≥ 2) after subtraction of
the anisotropy of the free peptide. Solid lines are fits to a hyperbolic equation with fitted
KD's of 4.7 ± 0.2 μM (LonS679A), 3.4 ± 0.4 μM (chimera211), and 1.5 ± 0.7 μM
(chimera307). (D) Binding of 160 nM fluorescent sul20 peptide to 6 μM LonS679A hexamer
or binding of 80 nM fluorescent sul20 peptide to 6 μM chimera211 hexamer was assayed by
anisotropy in the presence or absence of the specified concentrations of non-fluorescent
sul20 peptide or an unrelated control peptide (KREHGAANDENYCLAA).
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Figure 2.
Identification of the sul20 binding site in the Lon N domain. (A) Binding of fluorescein-
labeled sul20 peptide to LonS679A or variants containing multiple alanine-substitution
mutations was assayed by fluorescence anisotropy as described in the Fig. 1C legend. For
clarity, error bars (± SEM; N = 3) are only shown for the mutants with severe defects in
sul20 binding. (B) The positions of residues 14-15 and 33-38, which cause the largest
defects in sul20 binding, are colored red in a surface representation of the crystal structure of
part of the N domain (3LJC.pdb; Li et al., 2010). (C) Lon33-35 (3 μM hexamer equivalents)
behaved as a mixture of hexamers and dodecamers in sedimentation velocity analytical
ultracentrifugation performed at 20 °C and 16,000 rpm in 50 mM HEPES (pH 7.5), 150 mM
Wohlever et al. Page 15
Mol Microbiol. Author manuscript; available in PMC 2015 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
NaCl, 0.01 mM EDTA, 0.1 mM Tris (2-carboxyethyl) phosphine, 1 mM MgCl2, and 0.1
mM ATPγS.
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Figure 3.
Substrate degradation and ATP hydrolysis by Lon33-35 and wild-type Lon. (A) Degradation
of different concentrations of cp6-SFGFP-sul20 assayed by fluorescence (excitation 467 nm;
emission 511 nm). Values are means ± SEM (N ≥ 2). (B) Degradation of different
concentrations of β20-cp6-SFGFP assayed by fluorescence (excitation 467 nm; emission 511
nm). Values are means ± SEM (N ≥ 2). (C) Degradation of different concentrations of FITC-
casein (type II; Sigma) assayed by fluorescence (excitation 490 nm; emission 525 nm).
Values are means ± SEM (N = 3). (D) Degradation of F-β20-Q peptide (2 μM) was assayed
by fluorescence (excitation 320 nm; emission 422 nm) in the presence of increasing
concentrations of titinI27-sul20. Values are averages (N = 5). (E) ATP hydrolysis by wild-
type Lon or Lon33-35 was assayed in the presence of difference concentrations of
cp6-SFGFP-sul20. In panels A-C, lines are fits to the Hill form of the Michaelis-Menten
equation (rate = Vmax/(1+(KM/[S]n); see Table 1 for fitted parameters). In panel E, lines are
fits to basal + amp/(1+(Kapp/[S]n), where Vmax = basal + amp (see Table 1 for fitted
parameters). Lon or Lon33-35 concentrations were 0.3 μM (hexamer equivalents) in panels
A-C and 0.15 μM (hexamer equivalents) in panels D-E. The wild-type Lon data in panels B-
C was taken from Wohlever et al. (2013).
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Figure 4.
Inactivation of SulA. (A) To monitor Lon-mediated inactivation of SulA, E. coli W3110
Δlon::kanR cells transformed with low-copy pBAD33 plasmids expressing Lon or Lon
variants were irradiated with UV light, dilutions were spotted onto an LB agar plate, and the
plate was incubated overnight at room temperature. (B) As assayed by SDS-PAGE and
Western blotting with anti-Lon antibodies, chromosomal Lon in E. coli strain W3110 and
Lon variants expressed from pBAD33 plasmids in strain W3110 Δlon::kanR were present at
roughly similar intracellular levels following UV irradiation and 1 h of growth at room
temperature. (C) Binding of LonY398A (KD = 2.6 ± 0.1 μM) and LonE242Q (KD = 0.9 ± 0.1
μM) to the fluorescent sul20 peptide (200 nM). See Fig. 1C legend for conditions. (D) ATP
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hydrolysis by wild-type Lon, LonY398A, and LonE424Q (0.15 μM hexamer equivalents) was
assayed in the absence of substrate or in the presence of CM-titinI27-sul20 (20 μM) or CM-
titinI27-β20 (20 μM). (E) LonY398A (0.6 μM hexamer equivalents) did not detectably
degrade CM-titinI27-sul20 (10 μM) or CM-titinI27-β20 (10 μM) as assayed by SDS-PAGE.
(F) LonE424Q (0.6 μM hexamer equivalents) degraded CM-titinI27-sul20 (10 μM) or CM-
titinI27-β20 (10 μM) very slowly.
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Figure 5.
Suppression of proteotoxic stress and aggregation in vivo. (A) Lon-mediated rescue of cells
from proteotoxic stress caused by growth at 42 °C, under expression of DnaK and DnaJ, and
deletion of the chromosomal genes for lon, clpX, and clpP. E. coli strain BB7357 was
transformed with pBAD33 plasmids expressing wild-type Lon or Lon variants, dilutions
were spotted onto LB agar plates, and plates were incubated at 42 °C for ~12 h. (B)
Expression levels of mutants used in panel A were determined by Western blotting and
densitometry and normalized to the average value of Lon in E. coli strain W3110. Values are
averages ± SD (n ≥ 2). (C) Following growth for 1 h at 42 °C, aggregated proteins were
purified from strain BB7357 transformed with an empty vector or with pBAD33 variants
expressing wild-type Lon, Lon33-35/S697A, or LonE424Q/S697A, and were visualized after
SDS-PAGE by Coomassie-blue staining. The molecular weights of proteins in the SeeBlue*
Plus2 standard mixture are shown (Life Technologies).
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Table 1
Steady-state kinetic parameters
protein degradation ATP hydrolysis
substrate Lon variant Vmax min−1 enz−1 Km (μM) Hill constant Vmax min−1 enz−1 Kapp (μM) Hill constant
cp6-SFGFP-sul20 wild type
33-35
3.6 ± 0.3
0.15 ± 0.01
13 ± 2
13 ± 2
1.2 ± 0.1
1.2 ± 0.4
217 ±16
84 ± 13
9.3 ± 1.3
3 ± 0.8
1.2 ± 0.1
1.5 ± 0.6
P20-cp6-SFGFP wild type
33-35
2.3 ± 0.3
1.6 ± 0.1
21 ± 6.0
14 ± 1.0
1.2 ± 0.2
1.2 ± 0.2
143 ± 5
nd
2.6 ± 0.2
nd
1.7 ± 0.1
nd
FITC-casein wild type
33-35
4.4 ± 0.4
7.0 ± 2.0
16 ± 4.0
31 ± 23
1.2 ± 0.1
0.9 ± 2
nd
nd
nd
nd
nd
nd
CM-titinI27-sul20 wild type
33-35
Y398A
17.1 ± 0.7
10.5 ± 0.4
nd
12 ± 1.0
70 ± 5.0
nd
1.4 ± 0.2
1.4 ± 0.1
nd
200 ± 20
270 ± 70
23 ± 1
0.6 ± 0.1
13 ± 10
2.3 ± 0.5
1.3 ± 0.4
0.7 ± 0.2
3 ± 1.8
titinI27-sul20 wild type
33-35
2.0 ± 0.1
0.8 ± 0.3
29 ± 3.0
80 ± 70
1.5 ± 0.2
0.9 ± 0.2
118 ±5
79 ± 8
1.0 ± 0.1
3.5 ± 0.9
1.1± 0.1
1.2± 0.3
CM-titinI27-β20 wild type
33-35
Y398A
5.5 ± 0.1
nd
nd
18 ± 1.0
nd
nd
1.4 ± 0.1
nd
nd
174 ±7
250 ± 50
25 ± 2
1.6 ± 0.2
5.0 ± 3.0
1.4 ± 0.4
0.9 ± 0.1
0.7 ± 0.2
1 ± 0.3
Errors are from non-linear-least-squares fitting. The wild-type data for cp6-SFGFP-sul20 and cp6-SFGFP-|β20 are from Wohlever et al. (2013).
nd; not determined. Kapp values represent the substrate concentration required for 50% stimulation of ATP hydrolysis. Basal rates of ATP
hydrolysis in the absence of protein substrate were 10 ± 1 min−1 enz−1 (wild-type Lon), 10 ± 1 min−1 enz−1 (Lon33-35), and 13 ± 3 min−1
enz−1 (Lon Y398A). Enzyme concentrations were calculated as hexamer equivalents.
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